Medexus Pharma

Chicago, United States

Medexus Pharma is a rare disease pharmaceutical company focusing on therapeutic areas of rheumatology and auto-immune conditions.

$26.0M raised

Nov 2025

Post-IPO Debt

Biotechnology Medical Medical Device Pharmaceutical

Top Investors

MidCap Financial Lumira Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Medexus Pharma

How much funding has Medexus Pharma raised?

Medexus Pharma has raised $26.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in November 2025.

Who are Medexus Pharma's investors?

Medexus Pharma's investors include MidCap Financial, Lumira Ventures.

Where is Medexus Pharma headquartered?

Medexus Pharma is headquartered in Chicago, United States.

What does Medexus Pharma do?

Medexus Pharma is a rare disease pharmaceutical company focusing on therapeutic areas of rheumatology and auto-immune conditions.

What stage is Medexus Pharma at?

Medexus Pharma is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 17, 2025.

MLA

"Medexus Pharma — Funding & Investors." VCBacked, November 17, 2025, https://www.vcbacked.co/company/medexus-pharma. Accessed July 2, 2026.

APA

VCBacked. (2025). Medexus Pharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/medexus-pharma

Wikipedia (cite web)

{{cite web |title=Medexus Pharma — Funding & Investors |url=https://www.vcbacked.co/company/medexus-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 17, 2025.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K